Pre-earnings options volume in Capricor Therapeutics (CAPR) is normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 8.1%, or $1.41, after results are released. Median move over the past eight quarters is 7.7%.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- CAPR Earnings this Week: How Will it Perform?
- Capricor Therapeutics files to sell 2.8M shares of common stock for holders
- Capricor Therapeutics initiated with an Overweight at Piper Sandler
- Capricor Therapeutics Announces Major Public Offering
- Capricor Therapeutics 4.41M Spot Secondary prices at $17.00 per share